Advertisement

Allergo Journal International

, Volume 23, Issue 8, pp 274–280 | Cite as

Marker allergens of weed pollen – basic considerations and diagnostic benefits in the clinical routine

Part 16 of the Series Molecular Allergology
  • Teresa Stemeseder
  • Wolfgang Hemmer
  • Thomas Hawranek
  • Gabriele Gadermaier
Review article

Abstract

The term weed is referring to plants used as culinary herbs and medicinal plants as well as ecologically adaptive and invasive segetal plants. In Europe, pollen of ragweed, mugwort, English plantain and pellitory are the main elicitors of weed pollen allergies. Presently, 35 weed pollen allergens have been identified. The most relevant belong to the protein families of pectate lyases, defensin-like proteins, non-specific lipid transfer proteins, and Ole e 1-like proteins. The sensitization frequency depends on geographic regions and might affect more than 50 % of pollen allergic patients in distinct regions. Due to overlapping flowering seasons, similar habitats, polysensitizations and cross-reactive (pan)-allergens, it is difficult to diagnose genuine weed pollen sensitization using pollen extracts. Marker allergens for component-resolved diagnostics are available for the important weed pollen. These are Amb a 1 (ragweed), Art v 1 (mugwort), Pla l 1 (English plantain) and Par j 2 (pellitory). Molecule-based approaches can be used to identify the primary sensitizer and thus enable selection of the appropriate weed pollen extracts for allergen immunotherapy.

Key words

Weed pollen marker allergens mugwort ragweed English plantain pellitory component resolved diagnostics 

Abbreviations

AIT

Allergen immunotherapy

CCD

Cross-reactive carbohydrate determinants

IgE

Immunoglobulin E

nsLTP

Non-specific lipid transfer proteins

PR

Pathogenesis-related

SPT

Skin prick test

References

  1. 1.
    Ziska L, Knowlton K, Rogers C, Dalan D, Tierney N, Elder MA et al. Recent warming by latitude associated with increased length of ragweed pollen season in central North America. Proc Natl Acad Sci U S A 2011; 108:4248–51PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Smith M, Jager S, Berger U, Sikoparija B, Hallsdottir M, Sauliene I et al. Geographic and temporal variations in pollen exposure across Europe. Allergy 2014Google Scholar
  3. 3.
    Gadermaier G, Eichhorn S, Vejvar E, Weilnbock L, Lang R, Briza P et al. Plantago lanceolata: An important trigger of summer pollinosis with limited IgE cross-reactivity. J Allergy Clin Immunol 2014Google Scholar
  4. 4.
    Gadermaier G, Hauser M, Ferreira F. Allergens of weed pollen: An overview on recombinant and natural molecules. Methods 2014; 66:55–66PubMedCrossRefGoogle Scholar
  5. 5.
    Wopfner N, Jahn-Schmid B, Schmidt G, Christ T, Hubinger G, Briza P et al. The alpha and beta subchain of Amb a 1, the major ragweed-pollen allergen show divergent reactivity at the IgE and T-cell level. Mol Immunol 2009; 46:2090–7PubMedCrossRefGoogle Scholar
  6. 6.
    Razzera G, Gadermaier G, de Paula V, Almeida MS, Egger M, Jahn-Schmid B et al. Mapping the interactions between a major pollen allergen and human IgE antibodies. Structure 2010; 18:1011–21PubMedCrossRefGoogle Scholar
  7. 7.
    Himly M, Jahn-Schmid B, Dedic A, Kelemen P, Wopfner N, Altmann F et al. Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a de-fensin-like and a hydroxyproline-rich domain. Faseb J 2003; 17:106–8PubMedGoogle Scholar
  8. 8.
    Lombardero M, Garcia-Selles FJ, Polo F, Jimeno L, Chamorro MJ, Garcia-Casado G et al. Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens. Clin Exp Allergy 2004; 34:1415–21PubMedCrossRefGoogle Scholar
  9. 9.
    Moverare R, Larsson H, Carlsson R, Holmquist I. Mugwort-sensitized individuals from North Europe, South Europe and North America show different IgE reactivity patterns. Int Arch Allergy Immunol 2011; 154:164–72PubMedCrossRefGoogle Scholar
  10. 10.
    Oberhuber C, Ma Y, Wopfner N, Gadermaier G, Dedic A, Niggemann B et al. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients. Int Arch Allergy Immunol 2008; 145:94–101PubMedCrossRefGoogle Scholar
  11. 11.
    Dedic A, Gadermaier G, Vogel L, Ebner C, Vieths S, Ferreira F et al. Immune recognition of novel isoforms and domains of the mugwort pollen major allergen Art v 1. Mol Immunol 2009; 46:416–21PubMedCrossRefGoogle Scholar
  12. 12.
    Jahn-Schmid B, Fischer GF, Bohle B, Fae I, Gadermaier G, Dedic A et al. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. J Allergy Clin Immunol 2005; 115:399–404PubMedCrossRefGoogle Scholar
  13. 13.
    Leonard R, Wopfner N, Pabst M, Stadlmann J, Petersen BO, Duus JO et al. A new allergen from ragweed (Ambrosia artemisiifolia) with homology to art v 1 from mugwort. J Biol Chem 2010; 285:27192–200PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Gruber P, Gadermaier G, Bauer R, Weiss R, Wagner S, Leonard R et al. Role of the polypeptide backbone and post-translational modifications in cross-reactivity of Art v 1, the major mugwort pollen allergen. Biol Chem 2009; 390:445–51PubMedCrossRefGoogle Scholar
  15. 15.
    Egger M, Hauser M, Mari A, Ferreira F, Gadermaier G. The role of lipid transfer proteins in allergic diseases. Curr Allergy Asthma Rep 2010; 10:326–35PubMedCrossRefGoogle Scholar
  16. 16.
    Costa MA, Colombo P, Izzo V, Kennedy H, Venturella S, Cocchiara R et al. cDNA cloning, expression and primary structure of Par jI, a major allergen of Parietaria judaica pollen. FEBS Lett 1994; 341:182–6PubMedCrossRefGoogle Scholar
  17. 17.
    Stumvoll S, Westritschnig K, Lidholm J, Spitzauer S, Colombo P, Duro G et al. Identification of cross-reactive and genuine Parietaria judaica pollen allergens. J Allergy Clin Immunol 2003; 111:974–9PubMedCrossRefGoogle Scholar
  18. 18.
    Tordesillas L, Sirvent S, Diaz-Perales A, Villalba M, Cuesta-Herranz J, Rodriguez R et al. Plant lipid transfer protein allergens: no cross-reactivity between those from foods and olive and Parietaria pollen. Int Arch Allergy Immunol 2011; 156:291–6PubMedCrossRefGoogle Scholar
  19. 19.
    Sanchez-Lopez J, Tordesillas L, Pascal M, Munoz-Cano R, Garrido M, Rueda M et al. Role of Art v 3 in pollinosis of patients allergic to Pru p 3. J Allergy Clin Immunol 2014; 133:1018–25 e3PubMedCrossRefGoogle Scholar
  20. 20.
    Stemeseder T, Klinglmayr E, Moser S, Lang R, Himly M, Gschwendtner L et al., editors. Influences of environmental triggers and lifestyle on the development of allergic sensitizations. Congress of the European Academy of Allergy and Clinical Immunology; 2014; Kopenhagen, Denmark.Google Scholar
  21. 21.
    Boehme MW, Kompauer I, Weidner U, Piechotowski I, Gabrio T, Behrendt H. [Respiratory symptoms and sensitization to airborne pollen of ragweed and mugwort of adults in Southwest Germany]. Dtsch Med Wochenschr 2013; 138:1651–8PubMedCrossRefGoogle Scholar
  22. 22.
    Canis M, Becker S, Groger M, Kramer MF. IgE reactivity patterns in patients with allergic rhinoconjunctivitis to ragweed and mugwort pollens. Am J Rhinol Allergy 2012; 26:31–5PubMedCrossRefGoogle Scholar
  23. 23.
    Calabozo B, Diaz-Perales A, Salcedo G, Barber D, Polo F. Cloning and expression of biologically active Plantago lanceolata pollen allergen Pla l 1 in the yeast Pichia pastoris. Biochem J 2003; 372:889–96PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Asero R, Monsalve R, Barber D. Profilin sensitization detected in the office by skin prick test: a study of prevalence and clinical relevance of profilin as a plant food allergen. Clin Exp Allergy 2008; 38:1033–7PubMedCrossRefGoogle Scholar
  25. 25.
    Hirschwehr R, Heppner C, Spitzauer S, Sperr WR, Valent P, Berger U et al. Identification of common allergenic structures in mugwort and ragweed pollen. J Allergy Clin Immunol 1998; 101:196–206PubMedCrossRefGoogle Scholar
  26. 26.
    Jahn-Schmid B, Hauser M, Wopfner N, Briza P, Berger UE, Asero R et al. Humoral and cellular cross-reactivity between Amb a 1, the major ragweed pollen allergen, and its mugwort homolog Art v 6. J Immunol 2012; 188:1559–67PubMedCrossRefGoogle Scholar
  27. 27.
    Asero R, Wopfner N, Gruber P, Gadermaier G, Ferreira F. Artemisia and Ambrosia hypersensitivity: co-sensitization or co-recognition? Clin Exp Allergy 2006; 36:658–65PubMedCrossRefGoogle Scholar
  28. 28.
    Egger M, Mutschlechner S, Wopfner N, Gadermaier G, Briza P, Ferreira F. Pollen-food syndromes associated with weed pollinosis: an update from the molecular point of view. Allergy 2006; 61:461–76PubMedCrossRefGoogle Scholar
  29. 29.
    Heinzerling LM, Burbach GJ, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S et al. GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy 2009; 64:1498–506PubMedCrossRefGoogle Scholar
  30. 30.
    Gadermaier G, Hauser M, Egger M, Ferrara R, Briza P, Santos KS et al. Sensitization prevalence, antibody cross-reactivity and immunogenic peptide profile of Api g 2, the non-specific lipid transfer protein 1 of celery. PLoS One 2011; 6:e24150PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Wallner M, Pichler U, Ferreira F. Recombinant allergens for pollen immunotherapy. Immunotherapy 2013; 5:1323–38PubMedCrossRefGoogle Scholar
  32. 32.
    Hafner RP, Salapatek A, Patel D, Larche M, Laidler P, editors. Validation of Peptide Immunotherapy as a New Approach in the Treatment of Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes. J Allergy and Clin Immunology 2012;129 (2, Suppl):AB368Google Scholar

Copyright information

© Urban & Vogel 2014

Authors and Affiliations

  • Teresa Stemeseder
    • 1
  • Wolfgang Hemmer
    • 2
  • Thomas Hawranek
    • 3
  • Gabriele Gadermaier
    • 1
    • 4
    • 5
  1. 1.Department of Molecular BiologyUniversity of SalzburgSalzburgAustria
  2. 2.Floridsdorf Allergy CenterViennaAustria
  3. 3.Department of DermatologyParacelsus Private Medical University SalzburgSalzburgÖsterreich
  4. 4.Christian Doppler Laboratory for Biosimilar CharacterizationUniversity of SalzburgSalzburgAustria
  5. 5.Christian Doppler Laboratory for Biosimilar Characterization Department of Molecular BiologyUniversity of SalzburgSalzburgAustria

Personalised recommendations